Evidence map›Paper›PMID 40801848›Full record

ArticleJournal of Alzheimer's disease : JAD2025

The expression of insulin signaling and N-methyl-D-aspartate receptor genes in areas of gray matter atrophy is associated with cognitive function in type 2 diabetes.

Shelli R Kesler, Heather Cuevas, Kimberly A Lewis, Oscar Y Franco-Rocha, Elena Flowers

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Temporal dysregulation ofResearch square · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Shelli R KeslerDivision of Adult Health, School of Nursing, University of Texas at Austin, Austin, TX, USA.ORCID 0000-0002-0515-7942
Heather CuevasDivision of Adult Health, School of Nursing, University of Texas at Austin, Austin, TX, USA.ORCID 0000-0003-4314-6686
Kimberly A LewisDepartment of Nursing Excellence, Kaiser Permanente Richmond Medical Center, Richmond, CA, USA.ORCID 0000-0002-2590-8627
Oscar Y Franco-RochaDivision of Adult Health, School of Nursing, University of Texas at Austin, Austin, TX, USA.ORCID 0000-0002-5547-1518
Elena FlowersDepartment of Physiological Nursing, School of Nursing, University of California, San Francisco, CA, USA.ORCID 0000-0002-7054-7533

Funding

SUPPLEMENT TO ALZHEIMERS DISEASE PATIENT REGISTRYU01AG006786 · NIA · MAYO CLINIC ROCHESTER · PI GRAFF-RADFORD, JONATHAN, JACK, CLIFFORD R. · 1986 to 2023
$49.6M
Research Education ComponentP30AG062677 · NIA · MAYO CLINIC ROCHESTER · PI KEJAL KANTARCI · 2019 to 2026
$33.5M
NIA NIH HHS P30 AG062677NIA NIH HHS U01 AG006786
6 · The paper itself

Abstract

BackgroundType 2 diabetes (T2DM) is associated with brain abnormalities and cognitive dysfunction, including increased risk for Alzheimer's disease. However, the mechanisms of T2DM-related dementia remain poorly understood.ObjectiveWe evaluated the molecular properties of gray matter atrophy and cognitive decline in T2DM.MethodsWe obtained retrospective data from the Mayo Clinic Study of Aging for 271 individuals with T2DM and 542 non-diabetic controls (age 51-89, 62% male). We identified regions of significant gray matter atrophy in the T2DM group and then determined which genes were significantly expressed in these brain regions using imaging transcriptomics. We selected 15 candidate genes involved in insulin signaling, lipid metabolism, amyloid processing, N-methyl-D-aspartate-mediated neurotransmission, and calcium signaling.ResultsThe T2DM group demonstrated gray matter atrophy in regions of the default mode, frontal-parietal, and sensorimotor networks (p < 0.05 cluster threshold corrected for false discovery rate, FDR).

Indexed as

CognitionCognitive DysfunctionDiabetes Mellitus, Type 2Gray MatterInsulinReceptors, N-Methyl-D-AspartateAgedAged, 80 and overAtrophyBrainFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedRetrospective StudiesInsulinReceptors, N-Methyl-D-AspartateAlzheimer's diseaseneuroimagingtranscriptometype 2 diabetes

Identifiers

PMID40801848
PMCPMC12442454

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.